tldrdaily.news logo
Tag

Drug Classification

All articles tagged with #drug classification

politics1 year ago

"Delays in Cannabis Rescheduling: Understanding the Federal Roadblocks"

The DEA's classification of marijuana as a Schedule I drug, alongside heroin and LSD, has hindered research and created a legal limbo where pot is widely available in some states but federally illegal. President Biden has called for a review, and the DEA is considering reclassifying marijuana as a lower-level controlled substance, but full legalization is still a long way off due to bureaucratic hurdles, public opinion, and the stigma associated with marijuana.

via USA TODAY|
#dea#drug-classification#federal-law
health-and-medicine2 years ago

"Federal Scientists Advocate Marijuana Reclassification for Medical Use"

The Department of Health and Human Services released a 252-page review recommending the loosening of federal restrictions on marijuana, citing credible evidence of its medical benefits and lower potential for abuse compared to other scheduled drugs. This marks a significant departure from the federal government's longstanding classification of cannabis as a Schedule I drug. The review, conducted at the request of President Joe Biden, recommends moving marijuana to Schedule III, with the final decision resting with the Drug Enforcement Administration. The review also found that marijuana has a lower public health risk and potential for abuse than other scheduled drugs, based on scientific criteria and analysis of various medical conditions.

via POLITICO|
#drug-classification#fda-review#federal-restrictions
health-and-science2 years ago

"Federal Officials and 12 States Push for Marijuana Rescheduling"

Federal scientists have recommended removing marijuana from the most restrictive category of drugs, citing its potential medical benefits and lower risk compared to other controlled substances. The 250-page scientific review, obtained through a lawsuit, suggests reclassifying marijuana as a Schedule III drug, based on findings that it has therapeutic uses for conditions like anorexia and pain, and does not produce serious outcomes compared to drugs in Schedules I or II. The recommendation is being considered by the Drug Enforcement Administration, with potential implications for federal drug policy and the marijuana industry.

via The New York Times|
#decriminalization#drug-classification#federal-scientists
drug-policy2 years ago

"Potential Easing of U.S. Marijuana Restrictions: Implications Unveiled"

U.S. health regulators have recommended loosening restrictions on marijuana by moving it from Schedule I to Schedule III, which would make it easier to study and potentially reduce taxes for cannabis businesses. However, this change would not legalize recreational marijuana nationwide, and it would not directly address the issue of limited access to banking services. Critics argue that rescheduling is too incremental and that marijuana should be completely removed from the controlled substances list.

via PBS NewsHour|
#drug-classification#drug-policy#marijuana
drug-policy2 years ago

HHS Urges DEA to Reclassify Marijuana as Lower-Risk Drug

The Department of Health and Human Services (HHS) has recommended reclassifying marijuana as a schedule three substance, indicating it has a moderate to low potential for dependence, according to a letter obtained by Bloomberg News. Currently classified as a schedule one substance, this move could be a first step towards wider legalization. President Joe Biden had requested a review of marijuana's classification under federal law last year. As of April, 38 states and the District of Columbia allow for medical marijuana use, while 23 states and the District of Columbia have passed measures to regulate cannabis for adult non-medical use.

via USA TODAY|
#dea#drug-classification#drug-policy
drug-policy2 years ago

HHS Official Urges Reclassification of Marijuana to Lower-Risk Drug Category

The U.S. Department of Health and Human Services (HHS) has recommended that marijuana be reclassified as a Schedule III drug, according to a letter addressed to the Drug Enforcement Agency (DEA) administrator. Currently classified as a Schedule I drug, the move would ease restrictions on marijuana and align with the legalization efforts in about 40 U.S. states. The DEA confirmed receiving the letter and stated that it will initiate a review. Cannabis companies and advocates welcomed the HHS recommendation, citing the need to end the harm caused by marijuana prohibition.

via Reuters|
#dea#drug-classification#drug-policy
health2 years ago

Pennsylvania tightens control on xylazine, animal sedative linked to opioid overdoses.

Pennsylvania will classify xylazine, a powerful veterinary sedative that has been mixed with fentanyl in the state's opioid supply, as a Schedule III drug. This will allow for tighter record keeping, storage requirements, and prosecution for illegal possession and sale. Nitazenes, a class of synthetic opioids, will also be classified as a Schedule I narcotic. Xylazine contributed to 575 overdose deaths across 30 counties in 2021, and Philadelphia reported that 90% of street opioid samples contained the drug.

via The Philadelphia Inquirer|
#drug-classification#health#opioid-epidemic